China · Delayed Price · Currency is CNY Runben Biotechnology Statistics
Total Valuation
SHA:603193 has a market cap or net worth of CNY 9.65 billion. The enterprise value is 8.52 billion.
| Market Cap | 9.65B |
| Enterprise Value | 8.52B |
Important Dates
The next estimated earnings date is Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | Sep 18, 2025 |
Share Statistics
SHA:603193 has 404.59 million shares outstanding. The number of shares has decreased by -0.23% in one year.
| Current Share Class | 404.59M |
| Shares Outstanding | 404.59M |
| Shares Change (YoY) | -0.23% |
| Shares Change (QoQ) | -4.73% |
| Owned by Insiders (%) | 29.19% |
| Owned by Institutions (%) | 3.00% |
| Float | 79.95M |
Valuation Ratios
The trailing PE ratio is 31.42 and the forward PE ratio is 28.62.
| PE Ratio | 31.42 |
| Forward PE | 28.62 |
| PS Ratio | 6.36 |
| PB Ratio | 4.44 |
| P/TBV Ratio | 4.63 |
| P/FCF Ratio | 49.57 |
| P/OCF Ratio | 32.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.16, with an EV/FCF ratio of 43.77.
| EV / Earnings | 27.91 |
| EV / Sales | 5.61 |
| EV / EBITDA | 24.16 |
| EV / EBIT | 25.66 |
| EV / FCF | 43.77 |
Financial Position
The company has a current ratio of 12.51, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.51 |
| Quick Ratio | 9.02 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.01 |
| Interest Coverage | 3,596.35 |
Financial Efficiency
Return on equity (ROE) is 14.49% and return on invested capital (ROIC) is 31.14%.
| Return on Equity (ROE) | 14.49% |
| Return on Assets (ROA) | 9.17% |
| Return on Invested Capital (ROIC) | 31.14% |
| Return on Capital Employed (ROCE) | 15.25% |
| Weighted Average Cost of Capital (WACC) | 4.52% |
| Revenue Per Employee | 1.65M |
| Profits Per Employee | 331,515 |
| Employee Count | 921 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 4.93 |
Taxes
In the past 12 months, SHA:603193 has paid 56.71 million in taxes.
| Income Tax | 56.71M |
| Effective Tax Rate | 15.66% |
Stock Price Statistics
The stock price has decreased by -7.56% in the last 52 weeks. The beta is 0.05, so SHA:603193's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | -7.56% |
| 50-Day Moving Average | 24.60 |
| 200-Day Moving Average | 29.83 |
| Relative Strength Index (RSI) | 41.93 |
| Average Volume (20 Days) | 3,041,923 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603193 had revenue of CNY 1.52 billion and earned 305.33 million in profits. Earnings per share was 0.76.
| Revenue | 1.52B |
| Gross Profit | 880.90M |
| Operating Income | 331.99M |
| Pretax Income | 362.03M |
| Net Income | 305.33M |
| EBITDA | 351.44M |
| EBIT | 331.99M |
| Earnings Per Share (EPS) | 0.76 |
Balance Sheet
The company has 1.13 billion in cash and 1.76 million in debt, with a net cash position of 1.13 billion or 2.79 per share.
| Cash & Cash Equivalents | 1.13B |
| Total Debt | 1.76M |
| Net Cash | 1.13B |
| Net Cash Per Share | 2.79 |
| Equity (Book Value) | 2.17B |
| Book Value Per Share | 5.37 |
| Working Capital | 1.49B |
Cash Flow
In the last 12 months, operating cash flow was 297.73 million and capital expenditures -103.05 million, giving a free cash flow of 194.68 million.
| Operating Cash Flow | 297.73M |
| Capital Expenditures | -103.05M |
| Free Cash Flow | 194.68M |
| FCF Per Share | 0.48 |
Margins
Gross margin is 58.02%, with operating and profit margins of 21.87% and 20.11%.
| Gross Margin | 58.02% |
| Operating Margin | 21.87% |
| Pretax Margin | 23.85% |
| Profit Margin | 20.11% |
| EBITDA Margin | 23.15% |
| EBIT Margin | 21.87% |
| FCF Margin | 12.82% |
Dividends & Yields
This stock pays an annual dividend of 0.46, which amounts to a dividend yield of 1.93%.
| Dividend Per Share | 0.46 |
| Dividend Yield | 1.93% |
| Dividend Growth (YoY) | 22.86% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 79.01% |
| Buyback Yield | 0.23% |
| Shareholder Yield | 2.13% |
| Earnings Yield | 3.16% |
| FCF Yield | 2.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:603193 has an Altman Z-Score of 56.52 and a Piotroski F-Score of 5.
| Altman Z-Score | 56.52 |
| Piotroski F-Score | 5 |